share_log

HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $3 Price Target

Benzinga ·  May 15, 2023 12:50

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment